400
Participants
Start Date
February 20, 2022
Primary Completion Date
September 1, 2023
Study Completion Date
October 31, 2023
BBV152
Each participant will receive 2 doses of the investigational product intramuscular injection of either 6 μg of BBV15 vaccine or placebo.
RECRUITING
IACT Health, Columbus
RECRUITING
Palm Springs Community Health Center, Miami Lakes
RECRUITING
Angels Clinical Institute, Miami
RECRUITING
Suncoast Research Group LLC, Miami
RECRUITING
Jay Meyer Meridian Research, Lincoln
RECRUITING
Wellness Clinical Research, McKinney
RECRUITING
PRX Research, Dallas
RECRUITING
Voyage Medical, Tempe
RECRUITING
Meridian Research 3235 Academy Ave, Portsmouth
RECRUITING
Clinical Site Partners, Winter Park
Lead Sponsor
Ocugen
INDUSTRY